Premium
Natural and biotech‐derived therapeutic proteins: What is the future?
Author(s) -
Liu TehYung
Publication year - 2000
Publication title -
electrophoresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 158
eISSN - 1522-2683
pISSN - 0173-0835
DOI - 10.1002/(sici)1522-2683(20000501)21:9<1914::aid-elps1914>3.0.co;2-u
Subject(s) - glycoprotein , recombinant dna , function (biology) , human plasma , human proteins , genomic dna , computational biology , biology , blood proteins , biochemistry , urine , dna , chemistry , microbiology and biotechnology , gene , chromatography
A myriad of novel proteins and ligands of unknown function will be generated by the Human Genomic Project. Due to differences in post‐translational processing, proteins produced by recombinant DNA technology may not possess proper biological activity. One way to find their function is to search for their natural counterparts. Proteins are produced in the tissues, and many of them are secreted into plasma and excreted into urine. There is a virtually „unlimited” array of human proteins in our plasma and urine, many of them in a fully active form. They include small molecules like steroids, peptides, and large glycoproteins like human menopausal gonadotropin. A library of plasma and urinary proteins could be developed to serve as a reference for the novel proteins generated by the functional genomic projects.